Impact of hematologic complete response in the treatment of sporadic late‐onset nemaline myopathy associated with monoclonal gammopathy

Monoclonal gammopathy of undetermined significance (MGUS) may be associated with pathologies with severe neuromuscular manifestations such as sporadic late‐onset nemaline myopathy (SLONM). We describe a difficult to diagnose case of SLNOM with marked clinical improvement after achieving gammopathy c...

Descripción completa

Detalles Bibliográficos
Autores principales: Maia, Tânia, Bergantim, Rui, Costa, Henrique, Pinheiro, Jorge, Trigo, Fernanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283848/
https://www.ncbi.nlm.nih.gov/pubmed/34295490
http://dx.doi.org/10.1002/ccr3.4471
_version_ 1783723283268501504
author Maia, Tânia
Bergantim, Rui
Costa, Henrique
Pinheiro, Jorge
Trigo, Fernanda
author_facet Maia, Tânia
Bergantim, Rui
Costa, Henrique
Pinheiro, Jorge
Trigo, Fernanda
author_sort Maia, Tânia
collection PubMed
description Monoclonal gammopathy of undetermined significance (MGUS) may be associated with pathologies with severe neuromuscular manifestations such as sporadic late‐onset nemaline myopathy (SLONM). We describe a difficult to diagnose case of SLNOM with marked clinical improvement after achieving gammopathy complete hematologic response.
format Online
Article
Text
id pubmed-8283848
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82838482021-07-21 Impact of hematologic complete response in the treatment of sporadic late‐onset nemaline myopathy associated with monoclonal gammopathy Maia, Tânia Bergantim, Rui Costa, Henrique Pinheiro, Jorge Trigo, Fernanda Clin Case Rep Case Report Monoclonal gammopathy of undetermined significance (MGUS) may be associated with pathologies with severe neuromuscular manifestations such as sporadic late‐onset nemaline myopathy (SLONM). We describe a difficult to diagnose case of SLNOM with marked clinical improvement after achieving gammopathy complete hematologic response. John Wiley and Sons Inc. 2021-07-16 /pmc/articles/PMC8283848/ /pubmed/34295490 http://dx.doi.org/10.1002/ccr3.4471 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Maia, Tânia
Bergantim, Rui
Costa, Henrique
Pinheiro, Jorge
Trigo, Fernanda
Impact of hematologic complete response in the treatment of sporadic late‐onset nemaline myopathy associated with monoclonal gammopathy
title Impact of hematologic complete response in the treatment of sporadic late‐onset nemaline myopathy associated with monoclonal gammopathy
title_full Impact of hematologic complete response in the treatment of sporadic late‐onset nemaline myopathy associated with monoclonal gammopathy
title_fullStr Impact of hematologic complete response in the treatment of sporadic late‐onset nemaline myopathy associated with monoclonal gammopathy
title_full_unstemmed Impact of hematologic complete response in the treatment of sporadic late‐onset nemaline myopathy associated with monoclonal gammopathy
title_short Impact of hematologic complete response in the treatment of sporadic late‐onset nemaline myopathy associated with monoclonal gammopathy
title_sort impact of hematologic complete response in the treatment of sporadic late‐onset nemaline myopathy associated with monoclonal gammopathy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283848/
https://www.ncbi.nlm.nih.gov/pubmed/34295490
http://dx.doi.org/10.1002/ccr3.4471
work_keys_str_mv AT maiatania impactofhematologiccompleteresponseinthetreatmentofsporadiclateonsetnemalinemyopathyassociatedwithmonoclonalgammopathy
AT bergantimrui impactofhematologiccompleteresponseinthetreatmentofsporadiclateonsetnemalinemyopathyassociatedwithmonoclonalgammopathy
AT costahenrique impactofhematologiccompleteresponseinthetreatmentofsporadiclateonsetnemalinemyopathyassociatedwithmonoclonalgammopathy
AT pinheirojorge impactofhematologiccompleteresponseinthetreatmentofsporadiclateonsetnemalinemyopathyassociatedwithmonoclonalgammopathy
AT trigofernanda impactofhematologiccompleteresponseinthetreatmentofsporadiclateonsetnemalinemyopathyassociatedwithmonoclonalgammopathy

Ejemplares similares